About | Free Trial

Last Update

2016-03-08T00:00:00.000Z

This profile was last updated on // .

Is this you? Claim your profile.

Wrong Robert Ring?

Dr. Robert Ring H.

Chief Science Officer

Autism Speaks Inc

Direct Phone: (609) ***-****       

Autism Speaks Inc

1 East 33Rd Street 4Th Floor

New York, New York 10016

United States

Company Description

Autism Speaks is the world's leading autism science and advocacy organization. It is dedicated to funding research into the causes, prevention, treatments and cure for autism; increasing awareness of autism spectrum disorders; and advocating for the needs ... more

Find other employees at this company (517)

Background Information

Employment History

Senior Director and Head of the Autism Research Unit
Pfizer Inc

Department of Pharmacology and Physiology (Adjunct Faculty)
Drexel University

Chairman
Delivering Scientific Innovation for Autism LLC (DELSIA)

Position, Psychiatric Medicines Discovery and Development
Wyeth

Affiliations

Public Member
US government's Interagency Autism Coordinating Committee

Public Member
Interagency Autism Coordinating Committee

Public Member
IACC

Member
Society for Neuroscience

Member
American College of Neuropsychopharmacology

Member
International Society for Autism Research Inc

Member
Society of Biological Psychiatry

Education

B.A. double major
Fine Art and Biology
Westmont College

Ph.D.
Molecular Neurobiology
City of Hope

Ph.D.
Molecular Neurobiology
City of Hope National Medical Center

PhD

MIT

PhD

Princeton

Web References (197 Total References)


Sick Kids scientists figure out formula for predicting autism

www.autismunited.org [cached]

"[Dr. Scherer is] one of the pre-eminent researchers in the autism genetics field," said Dr. Robert Ring, chief science officer at Autism Speaks.

...
Dr. Ring says there are no medicines for the core symptoms of autism, which are repetitive behaviour and difficulty with social interactions and communication. Two antipsychotic drugs, originally developed for schizophrenia and bipolar disorder, are sometimes used to treat associated symptoms of autism. "The good news for families here is the activity in this area [drug development] is growing every day," says Dr. Ring.


Autism Statistics for 2014 - Research, Information & News

www.autismunited.org [cached]

The new statistics raise significant concerns about access to care, because autism is a lifelong disorder and the need for services only begins at diagnosis, says Robert Ring, chief science officer for the advocacy group Autism Speaks.

"Behind these numbers are real people," he says. "Every one of these numbers is a family that's coming to terms with the implications of the diagnosis for the lifespan of their loved one."
"We need a plan to respond to these numbers, a national strategy for autism, and leadership has to come from Washington," because every congressional district is affected, says Ring.
There are still disparities in awareness and access to care among minorities and poorer families, which can have a direct impact on a child's outcome, he says.


Autism Speaks’ New Chief Science Officer - AdultASD.org

www.adultasd.org [cached]

Rob Ring, Autism Speaks' New Chief Science Officer Tell us a little about yourself.


Archive - News Archives - AdultASD.org

www.adultasd.org [cached]

Rob Ring, Autism Speaks' New Chief Science Officer Tell us a little about yourself.


Robert H. ...

www.itasd.org [cached]

Robert H. Ring

Dr. Robert Ring was appointed Chief Science Officer (CSO) of Autism Speaks (AS), the world's largest autism science and advocacy foundation, in 2013.
A neuroscientist by training, Dr. Ring is responsible for overseeing a science program at AS that has invested over $220 million in basic and translational autism research since 2005. Dr. Ring joined Autism Speaks in 2011, and served as Vice President and Head of Translational Research until his appointment as CSO.
Prior to joining Autism Speaks, Dr. Ring served as Senior Director and Head of the Autism Research Unit at Pfizer, where he led the first research group in the pharmaceutical industry dedicated exclusively to the discovery and development of medicines for ASD and related neurodevelopmental disorders. Dr. Ring's work at Pfizer was preceded by 10-year tenure at Wyeth Research, where he distinguished himself in CNS medicines development, and held key leadership roles in the company's psychiatry division. In 2014, Dr. Ring was appointed to the US government's Interagency Autism Coordinating Committee (IACC).
He holds adjunct faculty appointments in the Departments of Psychiatry at Mount Sinai School of Medicine (New York) and Pharmacology and Physiology at Drexel University College of Medicine (Philadelphia). He earned a B.A. degree in both Fine Art and Biology (double-major) from Westmont College (Santa Barbara, CA), and Ph.D. in Molecular Neurobiology from the City of Hope National Medical Center (Monrovia, CA).

Similar Profiles

Other People with this Name

Other people with the name Ring

Donna Ring
Donna Jewelry Co

Heath Ring
Mystical

Linda Ring
SCA AB

Barclaycard Ring
Barclaycard US

Leo Ring
Daon Inc

Browse ZoomInfo's Business Contact Directory by City

Browse ZoomInfo's
Business People Directory

Browse ZoomInfo's
Advanced Company Directory